Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Touma

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Rheumatology|August 3, 2006
Successful treatment of Sjogren's syndrome with rituximabZ Touma, J Sayad, T Arayssi
Clinical Rheumatology|October 17, 2007
Oral bisphosphonates in treatment of transient osteoporosisL Kibbi, Z Touma, N Khoury, et al.
Lupus|November 14, 2009
SLEDAI-2K for a 30-day windowZ Touma, M B Urowitz, D D Gladman
Lupus|August 3, 2007
Longitudinal myelitis in patient with systemic lupus erythematosus, homozygous prothrombin G20210A and heterozygous MTHFR 677TZ Touma, S F Atweh, L Kibbi, et al.
Rheumatology (Oxford, England)|May 5, 2005
Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanerceptI Uthman, A Husari, Z Touma, et al.
Lupus|February 6, 2016
Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosusL Fidler, K J Keen, Z Touma, et al.
Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.
Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.
Lupus|August 14, 2016
Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosusG Cramarossa, M B Urowitz, J Su, et al.
Lupus|December 12, 2018
Disease course patterns in systemic lupus erythematosusK Tselios, D D Gladman, Z Touma, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Rheumatology|August 3, 2006
Successful treatment of Sjogren's syndrome with rituximabZ Touma, J Sayad, T Arayssi
Clinical Rheumatology|October 17, 2007
Oral bisphosphonates in treatment of transient osteoporosisL Kibbi, Z Touma, N Khoury, et al.
Lupus|November 14, 2009
SLEDAI-2K for a 30-day windowZ Touma, M B Urowitz, D D Gladman
Lupus|August 3, 2007
Longitudinal myelitis in patient with systemic lupus erythematosus, homozygous prothrombin G20210A and heterozygous MTHFR 677TZ Touma, S F Atweh, L Kibbi, et al.
Rheumatology (Oxford, England)|May 5, 2005
Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanerceptI Uthman, A Husari, Z Touma, et al.
Lupus|February 6, 2016
Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosusL Fidler, K J Keen, Z Touma, et al.
Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.
Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.
Lupus|August 14, 2016
Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosusG Cramarossa, M B Urowitz, J Su, et al.
Lupus|December 12, 2018
Disease course patterns in systemic lupus erythematosusK Tselios, D D Gladman, Z Touma, et al.
Pageof 2